The expression of SIRT1 in MS brains and in peripheral blood mononuclear cells (PBMCs) obtained from patients with RRMS was significant decrease during relapses when compared with the levels in controls and stable MS patients (Tegla et al. 2014). Here, SIRT1 is linked to myeloid sarcoma.